Orphan Reach

Orphan Reach is a leading Contract Research Organization (CRO) dedicated to exploring the complexities of trials in orphan indications. We are here to accelerate the clinical development of orphan drugs and facilitate access to new therapies urgently needed for patients with rare diseases. For our clients—innovative biotechnology companies—we provide global clinical development services with a particular focus on patient recruitment and retention. Our infrastructure enables rare disease patients across more than 100 countries worldwide to access these services. Central project management teams located in Europe, the United States, and Asia are responsible for coordinating our regional task forces and contributing their orphan drug expertise to expedite the use of new medications across a wide range of therapeutic areas.